Invention Grant
- Patent Title: Compounded transdermal pain management
-
Application No.: US13328369Application Date: 2011-12-16
-
Publication No.: US09724315B2Publication Date: 2017-08-08
- Inventor: Jay Richard Ray, II , Charles D. Hodge
- Applicant: Jay Richard Ray, II , Charles D. Hodge
- Applicant Address: US TX Conroe
- Assignee: CMPD Licensing, LLC
- Current Assignee: CMPD Licensing, LLC
- Current Assignee Address: US TX Conroe
- Agency: Akerman LLP
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K31/192 ; A61K31/195 ; A61K31/4168 ; A61K31/167 ; A61K31/197 ; A61K9/00 ; A61K47/02 ; A61K9/06

Abstract:
The present embodiments relate to topically delivered medication (compounded) for treatment of pain, inflammation, muscle fatigue, spasms, and/or other ailments. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The transdermal cream may include a salt load of approximately 30% or greater. The transdermal cream may include a unique base composition such that the transdermal cream may be able to remain stable and avoid degradation for six months or more and capable of effective delivery of active ingredient concentrations exceeding approximately 40% or more of the total formulation weight. The active ingredients may include a nerve depressant, NSAID, muscle relaxant, opiate agonist, local anesthetic, NMDA receptor antagonist, and a tricyclic antidepressant. In one embodiment, the transdermal cream may comprise ketamine HCL, gabapentin, clonidine HCL and baclofen. The transdermal cream may deliver an enhanced topical delivery flux of ketamine via a single transdermal application.
Public/Granted literature
- US20130085171A1 COMPOUNDED TRANSDERMAL PAIN MANAGEMENT Public/Granted day:2013-04-04
Information query